SAH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SAH is not a good buy right now. The stock is in a clear short- and medium-term downtrend (bearish moving averages and weakening MACD), and while it’s oversold enough to allow a short bounce near support, there is no Intellectia buy signal today and fundamentals show profit pressure. For an impatient buyer who doesn’t want to wait for a cleaner entry, the risk/reward is unfavorable at this moment; I would hold off and reassess after price stabilizes or after the upcoming earnings (2026-02-18).
Trend is bearish: SMA_200 > SMA_20 > SMA_5 confirms a downtrend across timeframes. Momentum is deteriorating: MACD histogram is negative (-0.362) and expanding lower, signaling increasing downside momentum. RSI_6 is 23.1 (oversold/washed-out conditions), which can support a reflex bounce but is not a confirmed reversal. Price (59.39) is sitting just below S1 (59.63) with the next support at S2 (58.12); a break below ~58.1 would likely extend the selloff. Overhead resistance starts at the pivot ~62.06, then ~64.50.
Intellectia Proprietary Trading Signals
can produce a short-term bounce if support holds. Upcoming earnings on 2026-02-18 (pre-market) can act as a catalyst if results/guide surprise positively. Citi remains bullish (Buy, PT $
and previously cited a near-term catalyst watch.
and JPM remains Underweight. Latest reported quarter profitability weakened sharply (net income and EPS down ~37% YoY), increasing the risk that earnings/revisions disappoint. Pattern-based forecast provided indicates negative bias over the next week (-2.43% expected value) with limited upside edge.
Latest quarter: 2025/Q3. Revenue grew to $3.9738B (+13.81% YoY), but profitability deteriorated: Net Income fell to $46.8M (-36.93% YoY) and EPS fell to $1.33 (-37.56% YoY). Gross margin slipped to 14.45% (down ~0.21 YoY), indicating growth is coming with margin/earnings pressure rather than operating leverage.
Recent trend is mixed-to-cautious with downward price target drift. JPMorgan keeps an Underweight and cut PT to $67 (from $70). Barclays keeps Equal Weight and cut PT to $69 (from $71). Morgan Stanley is Equal Weight with PT $68. The main bullish outlier is Citi’s upgrade to Buy with an $82 PT (from 2025-11), arguing headwinds were turning into tailwinds. Wall Street pros: resilient dealer models and potential used-vehicle momentum; cons: soft unit pressures and earnings/margin compression risk. Politician/congress activity: no recent congress trading data available; no notable politician activity provided.
